- Home
- DNOW vs OCUL Comparison
DNOW vs OCUL Comparison
Compare DNOW & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNOW
- OCUL
- Stock Information
- Founded
- DNOW 1862
- OCUL 2006
- Country
- DNOW United States
- OCUL United States
- Employees
- DNOW N/A
- OCUL N/A
- Industry
- DNOW Metal Fabrications
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- DNOW Industrials
- OCUL Health Care
- Exchange
- DNOW Nasdaq
- OCUL Nasdaq
- Market Cap
- DNOW 1.8B
- OCUL 1.8B
- IPO Year
- DNOW N/A
- OCUL 2014
- Fundamental
- Price
- DNOW $15.13
- OCUL $12.21
- Analyst Decision
- DNOW Buy
- OCUL Strong Buy
- Analyst Count
- DNOW 2
- OCUL 7
- Target Price
- DNOW $18.00
- OCUL $17.33
- AVG Volume (30 Days)
- DNOW 1.7M
- OCUL 2.3M
- Earning Date
- DNOW 08-06-2025
- OCUL 08-06-2025
- Dividend Yield
- DNOW N/A
- OCUL N/A
- EPS Growth
- DNOW N/A
- OCUL N/A
- EPS
- DNOW 0.75
- OCUL N/A
- Revenue
- DNOW $2,409,000,000.00
- OCUL $59,647,000.00
- Revenue This Year
- DNOW $4.72
- OCUL N/A
- Revenue Next Year
- DNOW $4.27
- OCUL $20.85
- P/E Ratio
- DNOW $20.17
- OCUL N/A
- Revenue Growth
- DNOW 4.74
- OCUL N/A
- 52 Week Low
- DNOW $11.42
- OCUL $5.79
- 52 Week High
- DNOW $18.45
- OCUL $12.27
- Technical
- Relative Strength Index (RSI)
- DNOW 55.28
- OCUL 81.02
- Support Level
- DNOW $15.08
- OCUL $11.23
- Resistance Level
- DNOW $15.61
- OCUL $11.47
- Average True Range (ATR)
- DNOW 0.50
- OCUL 0.46
- MACD
- DNOW 0.14
- OCUL 0.07
- Stochastic Oscillator
- DNOW 80.57
- OCUL 97.65
About DNOW NOW Inc.
Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.